A Warm Welcome to MedChem: The Frontiers in Medicinal Chemistry 2025

IF 3.4 4区医学 Q2 CHEMISTRY, MEDICINAL

ChemMedChem Pub Date : 2025-08-25 DOI:10.1002/cmdc.202500609

Matthias Schiedel, Marta Pinto, Andrea Unzue Lopez, Philipp Barbie, Felix Pape, Anika Tarasewicz, Gerhard Hessler, Peter Gmeiner, Christina Lamers, Matthias Gehringer

引用次数: 0

Abstract

The Frontiers in Medicinal Chemistry (FiMC), which represents the largest international Medicinal Chemistry conference in Germany, took place from April 1^st to 4^th, 2025, in Erlangen. The conference was a great success, bringing together more than 200 participants from around 20 countries. The outstanding program of the 4 day conference included 41 lectures by leading scientists from industry and academia as well as early career investigators. Moreover, 91 posters were presented in a highly interactive poster session.

Abstract Image

查看原文本刊更多论文

热烈欢迎参加MedChem：药物化学前沿2025。

2025年4月1日至4日，德国最大的国际药物化学会议——药物化学前沿会议（FiMC）在埃尔兰根举行。会议取得了巨大成功，来自20多个国家的200多名与会者齐聚一堂。在为期4天的会议上，有来自产业界和学术界的顶尖科学家以及早期职业研究者的41场演讲。此外，在一个高度互动的海报会议上，展示了91张海报。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ChemMedChem 医学-药学

CiteScore

6.70

自引率

2.90%

发文量

280

审稿时长

1 months

期刊介绍： Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.